Details
The microbiome market is one of the hottest areas for innovation in the life sciences space. We are seeing an uptick in both research and venture capital dollars going into the microbiome industry—both in humans and plants. As a result, the global microbiome market is expected to grow from $235.8 million in 2018 to $521.23 million by 2022.
Please join us for presentations by some of Boston’s most innovative companies in the space to learn about the science behind the microbiome, the utilization of emerging technologies, and various perspectives on the future of the industry.
Speakers- Geoffrey von Maltzahn, Co-founder, Chief Innovation Officer, Board Director, Indigo Ag
- Ryan Barrett, VP, Corporate Development & IP, Axial Biotherapeutics
- Matt Henn, Executive Vice President & Chief Scientific Officer, Seres Therapeutics
- Dr. Martha Herbert , Pediatric Neurologist and Research Neuroscientist, Massachusetts General Hospital
- John "Brent" Hunt, Founder & CEO, Soft Cell Biological Research
- Brian Klein, Senior Staff Scientist, Vedanta Biosciences
- Sonia Timberlake, VP of Research, Finch Therapeutics